-

Milken Institute COVID-19 Tracker Update Identifies More Than 100 Vaccines and Nearly 200 Treatments in Development

Nine vaccines and more than 50 treatment candidates reach clinical trials.

WASHINGTON--(BUSINESS WIRE)--The Milken Institute COVID-19 Treatment and Vaccine Tracker has identified more than 111 vaccines and 197 treatments in the pipeline to treat and prevent COVID-19. This is an increase from the 55 treatments and 38 vaccine candidates identified when the Institute first started tracking treatments and vaccines in early March.

Of these, nine vaccines and more than 50 treatments currently are in clinical trials. These include the RECOVERY study, the World Health Organization’s Solidarity Study, the National Institute of Allergy and Infectious Diseases’ Adaptive COVID-19 Treatment Trial, and the REMAP-CAP trial.

“I am encouraged by the accelerated process in developing these treatments and vaccines that traditionally take years,” said Esther Krofah, executive director of FasterCures, a center of the Milken Institute. “It is promising to see the collaboration between the pharmaceutical industry, academia, and research organizations driving progress at this scale."

A new, interactive version of the tracker makes the data searchable and sortable. Graphics capture the progress made, and the raw data can also be downloaded offline in a useable spreadsheet format. The tracker is updated regularly.

The COVID-19 Treatment and Vaccine Tracker is produced and maintained by FasterCures, with input from its Advisory Council, which includes three former FDA chiefs, a Nobel Laureate biologist, and key industry leaders. The information is compiled by publicly-available information from validated sources.

The Milken Institute welcomes input on new vaccines and treatments in development. Please email COVID19@milkeninstitute.org to contact the research team.

About FasterCures

FasterCures, a center of the Milken Institute, is working to build a system that is effective, efficient, and driven by a clear vision: patient needs above all else. We believe that transformative and life-saving science should be fully realized and deliver better treatments to the people who need them.

About the Milken Institute

The Milken Institute is a nonprofit, nonpartisan think tank that helps people build meaningful lives, in which they can experience health and well-being, pursue effective education and gainful employment, and access the resources required to create ever-expanding opportunities for themselves and their broader communities. For more information, visit https://milkeninstitute.org/.

Contacts

Jeff Valliere, FasterCures Director of Strategy
+1 202-441-2894 or jvalliere@milkeninstitute.org

Milken Institute

Details
Headquarters: Santa Monica, California
CEO: Richard Ditizio
Employees: 250
Organization: NON

Release Summary
Milken Institute COVID-19 Treatment and Vaccine Tracker identifies more than 111 vaccines and 197 treatments in development.
Release Versions

Contacts

Jeff Valliere, FasterCures Director of Strategy
+1 202-441-2894 or jvalliere@milkeninstitute.org

Social Media Profiles
More News From Milken Institute

Milken Institute Releases A Decade of Progress, A Decade to Act, a Collection of Essays and Interviews from 50 Leaders on Aging and Longevity

WASHINGTON--(BUSINESS WIRE)--The Milken Institute today released a new publication, The Future of Aging and Longevity: A Decade of Progress, A Decade to Act, a collection of essays, expert commentary, and interviews exploring aging and longevity from more than 50 leaders across sectors and disciplines. The report brings together intergenerational perspectives, reflecting 10 years of progress in aging and longevity and outlining priorities and solutions for the decade ahead. The report is center...

10 Companies Named Semifinalists of the $2 Million Milken-Motsepe Prize in Circular Economy

WASHINGTON--(BUSINESS WIRE)--The Milken Institute and the Motsepe Foundation announced the 10 teams advancing to the Semifinalist Round of the Milken-Motsepe Prize in Circular Economy, with $500,000 in unrestricted funding to innovative companies driving inclusive economic growth and sustainable development in Africa. A total of $2 million in non-dilutive capital will be distributed for this prize, along with opportunities for global visibility, mentorship, and investor connections. “Globally,...

Margaret Kuhlow Named Executive Vice President of Milken Institute Finance

WASHINGTON--(BUSINESS WIRE)--The Milken Institute today announced that Margaret Kuhlow has joined the organization as executive vice president of Milken Institute Finance. Kuhlow joins the Institute from the US Department of the Treasury, where she most recently served as deputy assistant secretary, overseeing international development finance policy. In her new role, Kuhlow will lead strategy development for Milken Institute Finance's research, convenings, and initiatives focused on expanding...
Back to Newsroom